Association of Dopamine Beta-Hydroxylase Polymorphisms with Bipolar Disorder

A central role for the gene encoding dopamine beta-hydroxylase in neuropsychiatric disorders is disclosed. Use of single nucleotide polymorphisms in the dopamine beta-hydroxylase gene for diagnosis, prediction of clinical course and treatment response, development of new treatments and development of cell-culture based and animal models for research and treatment are disclosed. Patent (Set) 09/852,967

Patents:
US 9,852,967

Inventor(s): De Paulo, Raymond

Type of Offer: Licensing



« More Medical Patents

---